top of page
Rechercher

France : Drug Eluting Stents (DES) market

  • Photo du rédacteur: Jean Manuel Toussaint
    Jean Manuel Toussaint
  • 16 juil. 2020
  • 1 min de lecture

Dernière mise à jour : 17 juil. 2020

DES market revenues have been flatenning over the past 3 years. In 2019, DES national tariffs (LPPR) decreased of -17.1% (€760 to €630) even though it doesn't reflect real-life tariffs, especially in public hospitals where prices are much lower. Consequently we observe a drop of -3.4% in total revenues (2018 vs 2019 : €201M.).

To get the full report, please contact-us : inquiries@ihmt-medicaldevice.com

Evolution of the Drug Eluting Stents (DES) market revenue over the past 9 years (2011-2019) with a split public and private hospitals
France : Drug Eluting Stents Market per Hospital (€, 2011-2019)

Comments

  • linkedin

©2001-2025 IHMT

bottom of page